National Asset Management, Inc. Organon & Co. Transaction History

National Asset Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$13.78 - $18.8 $139,715 - $190,613	10,139 New	10,139 $190,000
Q3 2023 Dec 01, 2023	SELL	$16.59 - $23.77 $17,369 - $24,887	-1,047 Reduced 9.36%	10,139 $176,000
Q2 2023 Jul 27, 2023	SELL	$19.27 - $24.63 $11,195 - $14,310	-581 Reduced 4.94%	11,186 $232,000
Q1 2023 May 17, 2023	SELL	$21.42 - $32.08 $29,516 - $44,206	-1,378 Reduced 10.48%	11,767 $276,000
Q4 2022 Feb 21, 2023	SELL	$23.31 - $28.61 $14,125 - $17,337	-606 Reduced 4.41%	13,145 $367,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $321,773 - $470,971	13,751 New	13,751 $323,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $219,245 - $269,382	-6,925 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$30.45 - $39.36 $26,582 - $34,361	-873 Reduced 11.2%	6,925 $242,000
Q4 2021 Jan 28, 2022	SELL	$28.67 - $37.13 $245,415 - $317,832	-8,560 Reduced 52.33%	7,798 $238,000
Q3 2021 Nov 16, 2021	BUY	$28.63 - $35.64 $82,511 - $102,714	2,882 Added 21.39%	16,358 $536,000
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $383,392 - $512,088	13,476 New	13,476 $408,000

795

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.88B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.